Although cFOS was initially believed to act as an oncogene [218,219], its role in cancer progression stands dubious since several studies have reported its cancer suppressive potential in hepatocellular carcinoma [220], ovarian [221,222] and prostate cancer [223]. The gene discussed is FOS; the disease is cancer.